Drug Guide
Levonorgestrel
Classification
Therapeutic: Hormonal Contraceptive/Progestin-only contraceptive
Pharmacological: Progestin
FDA Approved Indications
- Prevention of pregnancy
- Emergency contraception (Plan B, Plan B One-step, Opcicon One-step)
Mechanism of Action
Levonorgestrel primarily works by inhibiting ovulation, thickening cervical mucus to prevent sperm penetration, and altering endometrial lining to prevent implantation.
Dosage and Administration
Adult: Varies by product; e.g., for emergency contraception, typically a single dose of 1.5 mg taken as soon as possible within 72 hours of unprotected intercourse.
Pediatric: Not indicated for pediatric use.
Geriatric: Not indicated for use in elderly women.
Renal Impairment: No specific adjustments; caution advised.
Hepatic Impairment: Use with caution; no specific dosing recommendations.
Pharmacokinetics
Absorption: Rapid absorption after oral administration in emergency contraception.
Distribution: Widely distributed; high plasma protein binding (~98%).
Metabolism: Primarily hepatic via reduction and conjugation.
Excretion: Metabolites excreted mainly in urine; small amount in feces.
Half Life: Approximately 20 hours.
Contraindications
- Known or suspected pregnancy
- History of thromboembolic disorders
- Hepatic impairment or disease
- Porphyria
Precautions
- Use with caution in women with risk factors for cardiovascular disease; monitor for adverse effects.
Adverse Reactions - Common
- Irregular vaginal bleeding or spotting (Common)
- Headache (Common)
- Nausea (Common)
- Breast tenderness (Common)
Adverse Reactions - Serious
- Thromboembolic events (Rare)
- Liver dysfunction or tumors (Rare)
- Allergic reactions including rash, itching, swelling (Rare)
Drug-Drug Interactions
- Other hormonal medications, anticoagulants, enzyme inducers like rifampin and carbamazepine
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Assess pregnancy status, menstrual history, and risk factors for adverse effects.
Diagnoses:
- Risk of ineffective protection from pregnancy
- Risk for thromboembolic phenomena
Implementation: Administer as per product specifications, counsel about effectiveness, side effects, and proper use.
Evaluation: Monitor for pregnancy, evaluate for adverse reactions and compliance.
Patient/Family Teaching
- Use consistently and as directed for contraceptive effectiveness.
- Inform about possible side effects such as irregular bleeding.
- Explain emergency contraception instructions if applicable.
- Advise on signs of thromboembolic events and when to seek medical care.
Special Considerations
Black Box Warnings:
- Not to be used as routine contraception without medical consultation.
- Emergency contraception should be used within 72 hours for maximum effectiveness.
Genetic Factors: No specific genetic considerations.
Lab Test Interference: Hormonal contraceptives may affect ovarian and endometrial biopsy results.
Overdose Management
Signs/Symptoms: Nausea, vomiting, dizziness, or vaginal bleeding.
Treatment: Supportive care; no specific antidote.
Storage and Handling
Storage: Store at room temperature, away from light and moisture.
Stability: Stable under recommended storage conditions.